Abiopharma

Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals

Immuron Reports FY26 Preliminary Results

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million

Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results

General Announcement: Proposed Placement of Subscription Shares and Warrants - Further Extension of Long-Stop Date

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025216 <b>Size:</b> 1 MB

New Form FWP - CITIGROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025217 <b>Size:</b> 100 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025215 <b>Size:</b> 640 KB

Presentation for the capital market - H1-2026

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025214 <b>Size:</b> 653 KB

Financial Statements and Related Announcement: Half Yearly Results

New Form N-PX - Atlantic Union Bankshares Corp <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001104659-26-102816 <b>Size:</b> 544 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025213 <b>Size:</b> 766 KB